Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy

被引:25
|
作者
Pletz, MWR
McGee, L
Burkhardt, O
Lode, H
Klugman, KP
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Int Hlth, Atlanta, GA 30322 USA
[2] Otto Von Guericke Univ, Abt Pneumol & Internist Intens Med, D-39120 Magdeburg, Germany
[3] Free Univ Berlin, Lungenklin Heckeshorn Afill, D-14109 Berlin, Germany
关键词
D O I
10.1007/s10096-004-1254-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Reported here is the case of a patient with underlying chronic obstructive pulmonary disease (COPD) in whom ciprofloxacin treatment of a lower respiratory tract infection failed subsequent to ciprofloxacin treatment of an exacerbation of COPD several weeks earlier. During the second course of ciprofloxacin therapy, the patient's condition continued to deteriorate, and she was admitted to the intensive care unit. Bilateral pneumonia was diagnosed. Streptococcus pneumoniae, serotype 11A, resistant to ciprofloxacin was isolated from the sputum. Sequencing revealed a S79F mutation in parC and there was evidence of an efflux pump. The patient improved rapidly after administration of azithromycin and ampicillin/sulbactam. This report of treatment failure due to ciprofloxacin-resistant Streptococcus pneumoniae shows that fluoroquinolones should be avoided when treating patients who have recently received this class of antibiotics.
引用
收藏
页码:58 / 60
页数:3
相关论文
共 50 条
  • [1] Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy
    M. W. R. Pletz
    L. McGee
    O. Burkhardt
    H. Lode
    K. P. Klugman
    European Journal of Clinical Microbiology and Infectious Diseases , 2005, 24 : 58 - 60
  • [2] SUPERINFECTION WITH STREPTOCOCCUS-PNEUMONIAE DURING THERAPY WITH CIPROFLOXACIN
    GORDON, JJ
    KAUFFMAN, CA
    AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03): : 383 - 384
  • [3] Activities of newer fluoroquinolones against ciprofloxacin resistant Streptococcus pneumoniae
    Coyle, EA
    Kaatz, GW
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1654 - 1659
  • [4] Pharmacodynamics of Levofloxacin Against Characterized Ciprofloxacin-Resistant Streptococcus pneumoniae
    Lister, Philip D.
    POSTGRADUATE MEDICINE, 2008, : 46 - 52
  • [5] Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin
    Fuchs, PC
    Barry, AL
    Brown, SD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (05) : 671 - 672
  • [6] Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae
    Zhanel, GG
    Roberts, D
    Waltky, A
    Laing, N
    Nichol, K
    Smith, H
    Noreddin, A
    Bellyou, T
    Hoban, DJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (05) : 807 - 812
  • [7] Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae
    Lister, Philip D.
    POSTGRADUATE MEDICINE, 2008, 120 : 46 - 52
  • [8] Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae
    Zhanel, George G.
    James, Joanne
    Derkatch, Sheldon
    Laing, Nancy
    Noreddin, Ayman M.
    Hoban, Daryl J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) : 112 - 116
  • [9] Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada
    Nichol, KA
    Zhanel, GG
    Hoban, DJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 804 - 808
  • [10] Genetic characterization of fluoro quinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis
    de la Campa, AG
    Ferrandiz, MJ
    Tubau, F
    Pallarés, R
    Manresa, F
    Liñares, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) : 1419 - 1422